Home LiteratureArticle Details
PMID: 3498581 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.

Clinical and experimental immunology ·Vol. 68 ·No. 3 ·1987-06-00 ·Pages 638-47

Uchiyama T, Kamagata Y, Yan XJ, Kohno M, Yoshioka M, Fujikawa H, Igarashi H, Okubo M, Awano F, Saito-Taki T

Abstract

Toxic shock syndrome toxin-1 (TSST-1) is an exotoxin produced by Staphylococcus aureus isolated from patients with toxic shock syndrome. We investigated the proliferative response of human lymphocytes and their interleukin 2 (IL-2) production after stimulation with TSST-1 in vitro. Human cord blood mononuclear cells (HCBM) and human peripheral blood mononuclear cells (HPBM) could proliferate with TSST-1 stimulation. T cell-depleted HPBM showed only a marginal response to this toxin. A IL-2-like factor with a molecular weight of 15-18 kD was obtained from the supernatants of TSST-1-stimulated HPBM cultures. The factor was absorbed by CTLL-2 cells but not by T cell-depleted murine spleen cells, indicating that it is IL-2. HPBM are very sensitive to TSST-1: a low concentration of TSST-1 (0.01 ng/ml in 36 h stimulation) and a short period of stimulation (8 h at 10 ng/ml of the toxin) were fully effective for HPBM to produce substantial amounts of IL-2. Removal of T cells abrogated the TSST-1-induced IL-2 production by HPBM. Reconstituted cell cultures of nylon wool column-passed T cells and macrophages produced IL-2 by TSST-1 stimulation and, furthermore, the accessory activity of the macrophages could be partially replaced by a macrophage-derived factor containing interleukin 1. These findings indicate that T cells require macrophages or IL-1 for TSST-1-induced production of IL-2. The roles of lymphokines, including IL-2, in the development of this illness are discussed.

MeSH Terms
Bacterial Toxins Cells, Cultured Dose-Response Relationship, Immunologic Enterotoxins/pharmacology Humans Interleukin-2/biosynthesis Kinetics Lymphocyte Activation Lymphocytes/cytology Macrophages/immunology Mitosis Staphylococcus aureus Superantigens T-Lymphocytes/immunology
Chemicals
Bacterial Toxins Enterotoxins Interleukin-2 Superantigens enterotoxin F, Staphylococcal
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Uchiyama T
Department of Microbiology, Tokyo Women's Medical College, Japan.
Kamagata Y
Yan X J
Kohno M
Yoshioka M
Fujikawa H
Igarashi H
Okubo M
Awano F
Saito-Taki T
References (26)
26 references, click to expand
  1. Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins.
    Infect Immun. 1984 Apr;44(1):175-81 PMID: 6200439
  2. Purification and some physicochemical properties of toxic-shock toxin.
    Biochemistry. 1983 Aug 2;22(16):3907-12 PMID: 6615808
  3. Mechanism of lipopolysaccharide-induced immunosuppression: immunological activity of B cell subsets responding to T-dependent or T-independent antigens in lipopolysaccharide-preinjected mice.
    Infect Immun. 1984 Aug;45(2):367-71 PMID: 6235192
  4. Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro.
    Clin Immunol Immunopathol. 1984 Oct;33(1):99-110 PMID: 6332701
  5. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.
    J Infect Dis. 1985 Jan;151(1):65-72 PMID: 3871225
  6. Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.
    Infect Immun. 1985 Mar;47(3):598-604 PMID: 3156093
  7. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
    J Immunol. 1985 Oct;135(4):2865-75 PMID: 2993418
  8. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
    Immunology. 1986 Jun;58(2):203-8 PMID: 3486824
  9. T cell growth factor: parameters of production and a quantitative microassay for activity.
    J Immunol. 1978 Jun;120(6):2027-32 PMID: 307029
  10. A rapid method for the isolation of functional thymus-derived murine lymphocytes.
    Eur J Immunol. 1973 Oct;3(10):645-9 PMID: 4587740
  11. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
    Microbiol Immunol. 1986;30(5):469-83 PMID: 3489157
  12. Toxic-shock syndrome associated with phage-group-I Staphylococci.
    Lancet. 1978 Nov 25;2(8100):1116-8 PMID: 82681
  13. Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.
    J Immunol. 1979 Dec;123(6):2704-8 PMID: 315430
  14. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.
    N Engl J Med. 1980 Dec 18;303(25):1436-42 PMID: 7432402
  15. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.
    Ann Intern Med. 1980 Sep;93(3):399-406 PMID: 6159812
  16. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.
    Lancet. 1981 May 9;1(8228):1017-21 PMID: 6112412
  17. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.
    J Infect Dis. 1981 Apr;143(4):509-16 PMID: 6972418
  18. Molecular characterization of interleukin 2.
    Immunol Rev. 1982;63:167-209 PMID: 7042544
  19. T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations.
    J Immunol Methods. 1982;50(1):39-49 PMID: 6979583
  20. Clinical and laboratory manifestations of toxic shock syndrome.
    Ann Intern Med. 1982 Jun;96(6 Pt 2):843-7 PMID: 6212006
  21. Pathologic findings in twelve fatal cases of toxic shock syndrome.
    Ann Intern Med. 1982 Jun;96(6 Pt 2):852-7 PMID: 7091956
  22. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases.
    Ann Intern Med. 1982 Jun;96(6 Pt 2):858-64 PMID: 7091957
  23. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
    J Exp Med. 1982 Aug 1;156(2):454-64 PMID: 6980256
  24. Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome.
    J Infect Dis. 1983 Mar;147(3):391-8 PMID: 6833789
  25. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources.
    Infect Immun. 1983 Jun;40(3):1023-9 PMID: 6189784
  26. Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome.
    J Clin Invest. 1984 May;73(5):1312-20 PMID: 6609169
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1987-06-00
Pages
638-47
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1542756
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com